Suchergebnisse - "Dudnik, Elizabeth"

PubPharm (9)

1

Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer : A Population-Based Cohort Study

enthalten in: The oncologist | 2023

von Icht, O. | Leader, A. | Batat, E. | +8

2

dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50

enthalten in: Clinical lung cancer | 2022

von Holtzman, L. | Moskovitz, M. | Urban, D. | +10

3

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP) : a retrospective analysis from an early access program

enthalten in: Therapeutic advances in medical oncology | 2022

von Illini, O. | Fabikan, H. | Swalduz, A. | +28

4

Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer

enthalten in: Asia-Pacific journal of clinical oncology | 2021

von Icht, O. | Domachevsky, L. | Groshar, D. | +9

5

Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC : a retrospective chart review (REFLECT)

enthalten in: Therapeutic advances in medical oncology | 2021

von Addeo, A. | Hochmair, M. | Janzic, U. | +9

6

Nivolumab in Non-Small Cell Lung Cancer : Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

enthalten in: Frontiers in oncology | 2021

von Daher, S. | Lawrence, Y. | Dudnik, E. | +10

7

Can Ipilimumab restore immune response in advanced NSCLC after progression on anti-PD-1/PD-L1 agents?

enthalten in: Thoracic cancer | 2020

von Sternschuss, M. | Peled, N. | Allen, A. | +6

8

ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

enthalten in: Clinical lung cancer | 2017

von Zer, A. | Moskovitz, M. | Hwang, D. | +13

CommentIn: Clin Lung Cancer. 2018 Jan;19(1):e71-e72. - PMID 28818428

9

Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapy

enthalten in: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | 2016

von Dudnik, E. | Siegal, T. | Zach, L. | +6

1
[1]